Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Symic to Present at the 23rd Annual BioCentury NewsMakers in the Biotech Industry Conference

Posted on: 29 Aug 16

SAN FRANCISCO, Aug. 29, 2016 /PRNewswire/ -- Symic, a clinical stage biotherapeutics company developing therapies inspired by naturally occurring molecules of the extracellular matrix, today announced that Ken Horne, Chief Executive Officer, will present at the BioCentury NewsMakers in the Biotech Industry Conference.

Conference details:

Date: Friday, Sept. 9, 2016

Time: 11:30 a.m. EDT

Location: Millennium Broadway Hotel, New York

About Symic

Symic Bio is a clinical stage biotherapeutics company developing therapies inspired by proteoglycans, naturally occurring macromolecules of the extracellular matrix (ECM). The structural and regulatory properties of proteoglycans have potential applications in a wide variety of disease states. Symic Bio currently has two clinical candidates, one to address complications of vascular injury and one for disease modification in the treatment of osteoarthritis. In addition, Symic Bio is investigating applications in the areas of fibrosis and oncology.

For additional information please visit the company's website at, LinkedIn page at or follow on Twitter at

Media Contacts

David Schull or Rich Allan
Russo Partners, LLC
(212) 845-4271
(646) 942-5588


Editor's Details

Mike Wood

Last updated on: 29/08/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.